secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001420720-23-000065
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.03, 5.03, 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio effects 1-for-20 reverse stock split, reduces outstanding shares from 28.1M to 1.4M
--------------------------------------------------------------------------------

- Reverse stock split at 1:20 effective 12:01 a.m. ET Nov 29, 2023; shares continue trading as IBIO.
- Outstanding shares reduced from 28,100,733 to 1,405,036; fractional shareholders to receive cash.
- Stockholders approved reverse split with 5.8M for vs 5.2M against at Nov 27 annual meeting.
- Also adopted 2023 Omnibus Incentive Plan and elected directors Clark and Sender.
- New CUSIP number is 451033708; transfer agent Continental Stock Trust handling exchanges.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072023000065/0001420720-23-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072023000065/ibio-20231127x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-23-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer